Partial Purification and Characterization of a Growth Factor for Macrophage Progenitor Cells With High Proliferative Potential in Mouse Bone Marrow

• Published in: Blood 1982-08, Vol.60 (2), p.503-508
• Main Authors: Kriegler, A.B., Bradley, T.R., Januszewicz, E., Hodgson, G.S., Elms, E.F.
• Format: Article
• Language: English
• Subjects: Animals; Bone Marrow - analysis; Colony-Stimulating Factors - physiology; Growth Substances - isolation & purification; Growth Substances - pharmacology; Hematopoietic Stem Cells - drug effects; Hydrogen-Ion Concentration; Isoelectric Focusing; Macrophages - drug effects; Mice; Trypsin - pharmacology
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood.V60.2.503.503

A population of macrophage progenitor cells, with high proliferative potential, has recently been demonstrated in postfluorouracil-treated and normal mouse bone marrow (BM) in vitro, when a newly discovered growth factor (synergistic activity, SA) is combined with a macrophage colony-stimulating factor (CSF) as a proliferative stimulus.1,2 SA, shown to be present in human spleen and placental conditioned media (HSCM and HPCM, respectively),1,2 have been studied and found to be unstable to trypsin digestion and to heating at 50°C or above; stable between pH 4 and 9; nonadherent to Con-A-Sepharose; and to have an isoelectric point between pH 5 and 5.8 and a molecular weight of between 14,000 and 21,000 as indicated by gel filtraton chromatography. SAs from both HSCM and HPCM have been purified 89- and 122-fold, respectively, by precipitation of extraneous proteins at pH 5 followed by chromatographing twice on Sephacryl S200. Neither of these partially purified SAs contain any CSF for mouse BM. These results indicate that the SAs from HSCM and HPCM may be closely related and that they are structurally different from CSFs derived from various murine sources that have been shown to be stable to proteolytic enzymes and heat.